BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sasaki T, Isayama H, Nakai Y, Koike K. Current status of chemotherapy for the treatment of advanced biliary tract cancer. Korean J Intern Med. 2013;28:515-524. [PMID: 24009445 DOI: 10.3904/kjim.2013.28.5.515] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Han Y, Zhang H, Zhou Z, Liu R, Liu D, Bai M, Fan Q, Li J, Zhu K, Li H, Ning T, Ying G, Ba Y. Serum microRNAs as Biomarkers for the Noninvasive Early Diagnosis of Biliary Tract Cancer. Int J Gen Med 2021;14:1185-95. [PMID: 33833559 DOI: 10.2147/IJGM.S297371] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
2 Sasaki T. Chemotherapy for Unresectable Cholangiocarcinoma. Management of Pancreatic Cancer and Cholangiocarcinoma 2021. [DOI: 10.1007/978-981-16-2870-2_10] [Reference Citation Analysis]
3 Mo JW, Kim YM, Kim JH, Shin SY, Youn YH, Park H. Clinical outcomes after multiple self-expandable metallic stent placement using stent-in-stent technique for malignant gastric outlet obstruction. Medicine (Baltimore) 2020;99:e19432. [PMID: 32481247 DOI: 10.1097/MD.0000000000019432] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
4 D'Andrea MR, Gill CM, Umphlett M, Tsankova NM, Fowkes M, Bederson JB, Brastianos PK, Shrivastava RK. Brain Metastases from Biliary Tract Cancers: A Case Series and Review of the Literature in the Genomic Era. Oncologist 2020;25:447-53. [PMID: 31694894 DOI: 10.1634/theoncologist.2019-0306] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Bigdeli Shamloo MB, Nasiri M, Maneiy M, Dorchin M, Mojab F, Bahrami H, Naseri MS, Kiarsi M. Effects of topical sesame (Sesamum indicum) oil on the pain severity of chemotherapy-induced phlebitis in patients with colorectal cancer: A randomized controlled trial. Complementary Therapies in Clinical Practice 2019;35:78-85. [DOI: 10.1016/j.ctcp.2019.01.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
6 Yin L, Xu Q, Li J, Wei Q, Ying J. The efficiency and regimen choice of adjuvant chemotherapy in biliary tract cancer: A STROBE-compliant retrospective cohort study. Medicine (Baltimore) 2018;97:e13570. [PMID: 30558021 DOI: 10.1097/MD.0000000000013570] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
7 You MS, Lee SH, Kang J, Choi YH, Choi JH, Paik WH, Ryu JK, Kim Y. Metastatic Gallbladder Cancer Treated with Curative Surgery after Cyclic Chemotherapy and Biliary Drainage. Korean J Pancreas Biliary Tract 2018;23:41-47. [DOI: 10.15279/kpba.2018.23.1.41] [Reference Citation Analysis]
8 Lee DW, Im SA, Kim YJ, Yang Y, Rhee J, Na II, Lee KH, Kim TY, Han SW, Choi IS, Oh DY, Kim JH, Kim TY, Bang YJ. CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy. Cancer Res Treat 2017;49:807-15. [PMID: 28111425 DOI: 10.4143/crt.2016.326] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
9 Zhao S, Miao Y, Wang R, Guo H, Jin F, Guo X, Luo T. Efficacy and toxicities of adding molecular targeted agents to first-line chemotherapy in the treatment of advanced biliary tract cancer: a systematic review and meta-analysis. Onco Targets Ther 2016;9:6695-700. [PMID: 27822072 DOI: 10.2147/OTT.S110926] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
10 Njei B, McCarty TR, Varadarajulu S, Navaneethan U. Cost utility of ERCP-based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastrointest Endosc 2017;85:773-781.e10. [PMID: 27590963 DOI: 10.1016/j.gie.2016.08.020] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
11 Kim J, Jang Y, Shim J, Yu J, Shin DB, Park I. Metastasectomy for Recurrent or Metastatic Biliary Tract Cancers: A Single Center Experience. Soonchunhyang Med Sci 2016;22:1-7. [DOI: 10.15746/sms.16.001] [Reference Citation Analysis]
12 Odagiri T, Ishido K, Toyoki Y, Kudo D, Kimura N, Wakiya T, Tsutsumi S, Wakasa Y, Tsuya R, Hakamada K. Locally Advanced Gallbladder Cancer Treated with Chemotherapy and Subsequent Curative Resection. Jpn J Gastroenterol Surg, Nihon Shokaki Geka Gakkai zasshi 2016;49:1214-1221. [DOI: 10.5833/jjgs.2016.0031] [Reference Citation Analysis]
13 Dodagoudar C, Doval DC, Mahanta A, Goel V, Upadhyay A, Goyal P, Talwar V, Singh S, John MC, Tiwari S, Patnaik N. FOLFOX-4 as second-line therapy after failure of gemcitabine and platinum combination in advanced gall bladder cancer patients. Jpn J Clin Oncol. 2016;46:57-62. [PMID: 26603355 DOI: 10.1093/jjco/hyv148] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
14 Takahashi Y, Ebata T, Yokoyama Y, Igami T, Sugawara G, Mizuno T, Nimura Y, Nagino M. Surgery for Recurrent Biliary Tract Cancer: A Single-center Experience With 74 Consecutive Resections. Ann Surg. 2015;262:121-129. [PMID: 25405563 DOI: 10.1097/sla.0000000000000827] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 7.3] [Reference Citation Analysis]
15 Yang C, Liu Y, Xi WQ, Zhou CF, Jiang JL, Ma T, Ye ZB, Zhang J, Zhu ZG. Relationship between UGT1A1*6/*28 polymorphisms and severe toxicities in Chinese patients with pancreatic or biliary tract cancer treated with irinotecan-containing regimens. Drug Des Devel Ther. 2015;9:3677-3683. [PMID: 26229432 DOI: 10.2147/dddt.s86750] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
16 Cillo U, Spolverato G, Vitale A, Ejaz A, Lonardi S, Cosgrove D, Pawlik TM. Liver Resection for Advanced Intrahepatic Cholangiocarcinoma: A Cost-Utility Analysis. World J Surg 2015;39:2500-9. [DOI: 10.1007/s00268-015-3150-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
17 Park JO, Oh DY, Hsu C, Chen JS, Chen LT, Orlando M, Kim JS, Lim HY. Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review. Cancer Res Treat 2015;47:343-61. [PMID: 25989801 DOI: 10.4143/crt.2014.308] [Cited by in Crossref: 50] [Cited by in F6Publishing: 59] [Article Influence: 7.1] [Reference Citation Analysis]
18 Ulahannan SV, Rahma OE, Duffy AG, Makarova-Rusher OV, Kurtoglu M, Liewehr DJ, Steinberg SM, Greten TF. Identification of active chemotherapy regimens in advanced biliary tract carcinoma: a review of chemotherapy trials in the past two decades. Hepat Oncol 2015;2:39-50. [PMID: 25685318 DOI: 10.2217/hep.14.36] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
19 Sasaki T, Isayama H, Nakai Y, Ito Y, Yasuda I, Toda N, Yagioka H, Matsubara S, Hanada K, Maguchi H, Kamada H, Hasebe O, Mukai T, Okabe Y, Maetani I, Koike K. Treatment outcomes of chemotherapy between unresectable and recurrent biliary tract cancer. World J Gastroenterol 2014; 20(48): 18452-18457 [PMID: 25561816 DOI: 10.3748/wjg.v20.i48.18452] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
20 Okumura T, Nakamura J, Kai K, Ide Y, Nakamura H, Koga H, Ide T, Miyoshi A, Kitahara K, Noshiro H. Curative resection of gallbladder cancer with liver invasion and hepatic metastasis after chemotherapy with gemcitabine plus S-1: report of a case. World J Surg Oncol 2014;12:326. [PMID: 25367161 DOI: 10.1186/1477-7819-12-326] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
21 Hwang IG, Song HS, Lee MA, Nam EM, Lim J, Lee KH, Lee KT, Zang DY, Jang J. Treatment outcomes of gemcitabine alone versus gemcitabine plus platinum for advanced biliary tract cancer: a Korean Cancer Study Group retrospective analysis. Cancer Chemother Pharmacol 2014;74:1291-6. [DOI: 10.1007/s00280-014-2608-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
22 Sasaki T, Isayama H, Nakai Y, Takahara N, Hamada T, Mizuno S, Mohri D, Yagioka H, Kogure H, Arizumi T, Togawa O, Matsubara S, Ito Y, Yamamoto N, Sasahira N, Hirano K, Toda N, Tada M, Koike K. Clinical outcomes of secondary gastroduodenal self-expandable metallic stent placement by stent-in-stent technique for malignant gastric outlet obstruction. Dig Endosc. 2015;27:37-43. [PMID: 24995858 DOI: 10.1111/den.12321] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]